Pfizer Inc. reports $14.45 billion revenue for quarter ended March 29, 2026, up 5.4%

ยท PFE

Pfizer Inc. reported revenue of $14.45 billion for the quarter ended March 29, 2026, an increase of 5.4% from the same quarter a year earlier ($13.71 billion).

For the same period it posted net income of $2.69 billion, down 9.4%, or $0.47 per diluted share (0.52 a year earlier).

That is a net margin of 18.6%.

On Sanad's AAOIFI Standard 21 screen, Pfizer Inc. is currently not compliant: interest-bearing debt is 38.6% of market capitalisation (limit 30%), and impure income is 1% of revenue (limit 5%).

Source: 10-Q filed with the U.S. Securities and Exchange Commission on May 5, 2026. View the filing. Figures are as reported in the filing. This is information, not investment advice.

More Pfizer Inc. news